FOXA1 and neoplasm: Based on our findings that reduced ANP32E expression levels associated with tumor stage progression, perhaps through regulation of FOXA1 binding, we next sought to determine the relationship between ANP32E expression and tumor phenotype, using the tumor transcriptome as a read-out.